Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
This program is designed to provide expanded access to MK-0518 prior to the product’s approval and availability on the market. The safety and tolerability of MK-0518 400 mg b.i.d. for the treatment of HIV-1 infection will be monitored.
Critère d'inclusion
- HIV-1 infected patients